Literature DB >> 22695164

Role of signal-to-cutoff ratios in hepatitis C virus antibody detection.

Marco Moretti1, Barbara Pieretti, Annamaria Masucci, Davide Sisti, Marco Rocchi, Ernesto Delprete.   

Abstract

We reviewed results from 12,800 samples tested for hepatitis C virus (HCV) antibody detection in our laboratory by screening (Ortho chemiluminescence immunoassay [CIA]) and supplemental tests (Chiron recombinant immunoblot assay [RIBA]). We found that a signal-to-cutoff (S/Co) ratio of 10.3 was, in our setting, the most efficient cutoff point to improve the diagnostic algorithm of HCV infection.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22695164      PMCID： PMC3416074          DOI： 10.1128/CVI.00175-12

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


  14 in total

1.  Chemiluminescence assay improves specificity of hepatitis C antibody detection.

Authors:  D Robert Dufour; Mageli Talastas; Maria D A Fernandez; Barbara Harris
Journal:  Clin Chem       Date:  2003-06       Impact factor: 8.327

2.  Cost effectiveness of testing strategies for chronic hepatitis C.

Authors:  Michael K Chapko; Kevin L Sloan; John W Davison; D Robert Dufour; Daniel D Bankson; Michael Rigsby; Jason A Dominitz
Journal:  Am J Gastroenterol       Date:  2005-03       Impact factor: 10.864

Review 3.  Hepatitis C and liver transplantation.

Authors:  Robert S Brown
Journal:  Nature       Date:  2005-08-18       Impact factor: 49.962

4.  Public Health Service inter-agency guidelines for screening donors of blood, plasma, organs, tissues, and semen for evidence of hepatitis B and hepatitis C.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1991-04-19

5.  Improved reflexive testing algorithm for hepatitis C infection using signal-to-cutoff ratios of a hepatitis C virus antibody assay.

Authors:  Keane K Y Lai; Ming Jin; Shan Yuan; Meaghan F Larson; Jason A Dominitz; Daniel D Bankson
Journal:  Clin Chem       Date:  2011-05-12       Impact factor: 8.327

6.  Sensitivity and specificity of third-generation hepatitis C virus antibody detection assays: an analysis of the literature.

Authors:  C Colin; D Lanoir; S Touzet; L Meyaud-Kraemer; F Bailly; C Trepo
Journal:  J Viral Hepat       Date:  2001-03       Impact factor: 3.728

7.  Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Centers for Disease Control and Prevention.

Authors:  Miriam J Alter; Wendi L Kuhnert; Lyn Finelli
Journal:  MMWR Recomm Rep       Date:  2003-02-07

8.  Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay.

Authors:  C L Van der Poel; H T Cuypers; H W Reesink; A J Weiner; S Quan; R Di Nello; J J Van Boven; I Winkel; D Mulder-Folkerts; P J Exel-Oehlers
Journal:  Lancet       Date:  1991-02-09       Impact factor: 79.321

9.  Efficiency of the ortho VITROS assay for detection of hepatitis C virus-specific antibodies increased by elimination of supplemental testing of samples with very low sample-to-cutoff ratios.

Authors:  Margret Oethinger; Donald R Mayo; JoAnne Falcone; Pankaj K Barua; Brigitte P Griffith
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

10.  Diagnosis of hepatitis C virus (HCV) infection using an immunodominant chimeric polyprotein to capture circulating antibodies: reevaluation of the role of HCV in liver disease.

Authors:  D Y Chien; Q L Choo; A Tabrizi; C Kuo; J McFarland; K Berger; C Lee; J R Shuster; T Nguyen; D L Moyer
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205
View more
  8 in total

1.  Retrospective analysis on the diagnostic performances and signal-to-cut-off ratios of the Elecsys Anti-HCV II assay.

Authors:  Banseok Kim; Hyo Jun Ahn; Min Hyuk Choi; Yongjung Park
Journal:  J Clin Lab Anal       Date:  2017-02-10       Impact factor: 2.352

Review 2.  KASL clinical practice guidelines: management of hepatitis C.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2016-03-28

3.  Hepatitis C Virus Antibody Screening in a Cohort of Pregnant Women: Identifying Seroprevalence and Risk Factors.

Authors:  Mona Prasad; George R Saade; Grecio Sandoval; Brenna L Hughes; Uma M Reddy; Lisa Mele; Ashley Salazar; Michael W Varner; Cynthia Gyamfi-Bannerman; John M Thorp; Alan T N Tita; Geeta K Swamy; Edward K Chien; Brian M Casey; Alan M Peaceman; Yasser Y El-Sayed; Jay D Iams; Ronald S Gibbs; Baha Sibai; Nicholas Wiese; Saleem Kamili; George A Macones
Journal:  Obstet Gynecol       Date:  2020-04       Impact factor: 7.623

4.  Usefulness of a fourth generation ELISA assay for the reliable identification of HCV infection in HIV-positive adults from Gabon (Central Africa).

Authors:  François Rouet; Luc Deleplancque; Berthold Bivigou Mboumba; Jeanne Sica; Augustin Mouinga-Ondémé; Florian Liégeois; Alain Goudeau; Frédéric Dubois; Catherine Gaudy-Graffin
Journal:  PLoS One       Date:  2015-01-24       Impact factor: 3.240

5.  Predicting factors of present hepatitis C virus infection among patients positive for the hepatitis C virus antibody.

Authors:  Chi Hoon Lee; Hyun Phil Shin; Joung Il Lee; Kwang Ro Joo; Jae Myung Cha; Jung Won Jeon; Jun Uk Lim; Joon Ki Min; Dong Hee Kim; Sung Wook Kang; Hyun Jun Joung
Journal:  Clin Mol Hepatol       Date:  2013-12-28

6.  KASL clinical practice guidelines: management of hepatitis C.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2014-06-30

7.  Prevalence and trends of markers of hepatitis B virus, hepatitis C virus and human Immunodeficiency virus in Argentine blood donors.

Authors:  Diego M Flichman; Jorgelina L Blejer; Beatriz I Livellara; Viviana E Re; Sonia Bartoli; Juan A Bustos; Claudia P Ansola; Susana Hidalgo; Martin E Cerda; Alicia E Levin; Adriana Huenul; Victoria Riboldi; Elena M C Treviño; Horacio J Salamone; Felix A Nuñez; Robert J Fernández; Juan F Reybaud; Rodolfo H Campos
Journal:  BMC Infect Dis       Date:  2014-04-23       Impact factor: 3.090

8.  The Role of the Signal-to-Cutoff Ratio in Automated Anti-HCV Chemiluminescent Immunoassays by Referring to the Nucleic Acid Amplification Test and the Recombinant Immunoblot Assay.

Authors:  Moon Suk Choi; Kyunghoon Lee; Yun Ji Hong; Eun Young Song; Dal Sik Kim; Junghan Song
Journal:  Ann Lab Med       Date:  2018-09       Impact factor: 3.464
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.